These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 3026605)

  • 1. Long-term effects of intravenous hyperalimentation administered during intensive chemotherapy for small cell bronchogenic carcinoma.
    Valdivieso M; Frankmann C; Murphy WK; Benjamin RS; Barkley HT; McMurtrey MJ; Jeffries DG; Welch SR; Bodey GP
    Cancer; 1987 Jan; 59(2):362-9. PubMed ID: 3026605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of intravenous hyperalimentation as an adjunct to intensive chemotherapy for small cell bronchogenic carcinoma.
    Valdivieso M; Bodey GP; Benjamin RS; Barkley HT; Freeman MB; Ertel M; Smith TL; Mountain CF
    Cancer Treat Rep; 1981; 65 Suppl 5():145-50. PubMed ID: 6809324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of intensive induction chemotherapy for extensive-disease small cell bronchogenic carcinoma in protected environment-prophylactic antibiotic units.
    Valdivieso M; Cabanillas F; Keating M; Barkley HT; Murphy WK; Burgess MA; Frazier H; Chen T; Bodey GP
    Am J Med; 1984 Mar; 76(3):405-12. PubMed ID: 6322584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized clinical trial in bronchogenic small-cell carcinoma evaluating alternating maintenance therapy of vincristine, adriamycin, procarbazine, and etoposide (VAPE) with cyclophosphamide, CCNU, and methotrexate (CCM) versus CCM maintenance alone in complete responders following VAPE induction and late intensification.
    Broder LE; Sridhar KS; Selawry OS; Charyulu KN; Rao RK; Saldana MJ; Donnelly EJ; Raub WA
    Am J Clin Oncol; 1994 Dec; 17(6):527-37. PubMed ID: 7977175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose intensification therapy with autologous bone marrow support for limited small-cell bronchogenic carcinoma.
    Spitzer G; Farha P; Valdivieso M; Dicke K; Zander A; Vellekoop L; Murphy WK; Dhingra HM; Umsawasdi T; Chiuten D
    J Clin Oncol; 1986 Jan; 4(1):4-13. PubMed ID: 3510281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extensive-stage small-cell bronchogenic carcinoma: intensive induction chemotherapy with high-dose cyclophosphamide plus high-dose etoposide.
    Johnson DH; Wolff SN; Hainsworth JD; Porter LL; Grosh WW; Hande KR; Greco FA
    J Clin Oncol; 1985 Feb; 3(2):170-5. PubMed ID: 2981981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, controlled phase III study of cyclophosphamide, doxorubicin, and vincristine with etoposide (CAV-E) or teniposide (CAV-T), followed by recombinant interferon-alpha maintenance therapy or observation, in small cell lung carcinoma patients with complete responses.
    Tummarello D; Mari D; Graziano F; Isidori P; Cetto G; Pasini F; Santo A; Cellerino R
    Cancer; 1997 Dec; 80(12):2222-9. PubMed ID: 9404698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of extensive stage small cell bronchogenic carcinoma. Effects of variation in intensity of induction chemotherapy.
    Brower M; Ihde DC; Johnston-Early A; Bunn PA; Cohen MH; Carney DN; Makuch RW; Matthews MJ; Radice PA; Minna JD
    Am J Med; 1983 Dec; 75(6):993-1000. PubMed ID: 6316784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined methotrexate and high-dose vincristine chemotherapy with radiation therapy for small cell bronchogenic carcinoma.
    Holoye PY; Libnoch JA; Anderson T; Cox JD; Byhardt RW; Hoffmann RG
    Cancer; 1985 Apr; 55(7):1436-45. PubMed ID: 2983855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Small cell lung carcinoma: role of thoracic irradiation and its timing in relation to chemotherapy].
    Payne DG; Murray N; Warde P
    Bull Cancer; 1994 Feb; 81(2):119-28. PubMed ID: 7894117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Short-term induction and cyclic maintenance therapy in inoperable small cell bronchial cancer].
    Niederle N; Krischke W; Schulz U; Schmidt CG; Seeber S
    Klin Wochenschr; 1982 Aug; 60(16):829-38. PubMed ID: 6290754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cisplatin and etoposide regimen is superior to cyclophosphamide, epirubicin, and vincristine regimen in small-cell lung cancer: results from a randomized phase III trial with 5 years' follow-up.
    Sundstrøm S; Bremnes RM; Kaasa S; Aasebø U; Hatlevoll R; Dahle R; Boye N; Wang M; Vigander T; Vilsvik J; Skovlund E; Hannisdal E; Aamdal S;
    J Clin Oncol; 2002 Dec; 20(24):4665-72. PubMed ID: 12488411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cisplatin/etoposide versus ifosfamide/etoposide combination chemotherapy in small-cell lung cancer: a multicenter German randomized trial.
    Wolf M; Havemann K; Holle R; Gropp C; Drings P; Hans K; Schroeder M; Heim M; Dommes M; Mende S
    J Clin Oncol; 1987 Dec; 5(12):1880-9. PubMed ID: 2824710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experience of a German multicenter study group with ifosfamide in small cell lung cancer.
    Havemann K; Wolf M; Drings P; Hans K; Schroeder M; Holle R; Flechtner H; Goerg R; Becker H
    Semin Oncol; 1989 Feb; 16(1 Suppl 3):9-18. PubMed ID: 2539648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of a combined chemo-radiotherapeutic program in 61 patients affected by small cell lung cancer.
    Tummarello D; Guidi F; Porfiri E; Isidori P; Raspugli M; Cellerino R
    Tumori; 1988 Apr; 74(2):207-11. PubMed ID: 2835845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between myelosuppression and chemotherapeutic response in small cell bronchogenic carcinoma.
    Holoye PY
    Exp Hematol; 1985; 13 Suppl 16():72-9. PubMed ID: 2985416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined radiotherapy and chemotherapy with cyclophosphamide, adriamycin, methotrexate, procarbazine (CAMP) in 64 consecutive patients with epidermoid bronchogenic carcinoma, limited disease: a prospective study.
    Trovò MG; Tirelli U; De Paoli A; Franchin G; Roncadin M; Magri M; Galligioni E; Veronesi A; Tumolo S; Carbone A; Grigoletto E
    Int J Radiat Oncol Biol Phys; 1982 Jun; 8(6):1051-4. PubMed ID: 7107434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclic alternating combination chemotherapy for small cell bronchogenic carcinoma.
    Cohen MH; Ihde DC; Bunn PA; Fossieck BE; Matthews MJ; Shackney SE; Johnston-Early A; Makuch R; Minna JD
    Cancer Treat Rep; 1979 Feb; 63(2):163-70. PubMed ID: 221114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomised trial of three or six courses of etoposide cyclophosphamide methotrexate and vincristine or six courses of etoposide and ifosfamide in small cell lung cancer (SCLC). I: Survival and prognostic factors. Medical Research Council Lung Cancer Working Party.
    Bleehen NM; Girling DJ; Machin D; Stephens RJ
    Br J Cancer; 1993 Dec; 68(6):1150-6. PubMed ID: 8260367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination chemotherapy and radiation therapy for small cell carcinoma of the lung.
    Maurer LH; Tulloh M; Eagan RT; Forcier RJ; House R
    Cancer Chemother Rep 3; 1973 Mar; 4(2):171-6. PubMed ID: 4354041
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.